Navigation Links
NORTHWEST BIO Announces Positive Third Quarter Progress
Date:10/6/2011

160;The NORTHWEST BIO trial is a double-blind randomized controlled trial, with a "treated" group and a "control" group, as is required for late stage clinical trials.  However, unlike other current immune therapy trials for cancer, the NORTHWEST BIO trial has been carefully designed so that it provides an opportunity for all patients in the "control group" to "cross over" and receive the DCVax® immune therapy after a certain point is passed.  As a result, the NORTHWEST BIO trial design will not only provide randomized, placebo-controlled data,  it will also allow all patients in the trial to ultimately receive the DCVax® treatment -- including the patients who are assigned to the "control group."  Physicians and patients are expressing strong interest and support for this trial design.

As part of NORTHWEST BIO's program to increase the visibility of its progress, it also announced today that it has entered into an agreement to have company information made available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have corporate information disseminated to users of Standard & Poor's Market Scope Advisor, used by more than 100,000 investment advisors.  The first step under this program is a basic listing of NORTHWEST BIO in the Daily News section of Standard Corporation Records, a recognized manual for secondary trading in up to 38 states under their Blue Sky Laws, thereby qualifying NWBO for trading in those states.

Standard and Poor's also makes available a weekly updated Stock Report on Company initiatives and strategy, as well as basic stock-related and financial information. The first Stock Report on NORTHWEST BIO is expected to be available through the Market Scope Advisor public website at www.advisorinsight.com by mid-October following completion of the initial Report and
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011
2. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
3. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
4. Dendreon CEO Dr. Mitchell Gold Named Ernst & Young Entrepreneur Of The Year® 2011 Pacific Northwest Award Winner
5. Northwest Biotherapeutics Announces Change and Expansion of Management Team
6. Northwest Biotherapeutics Announces Series of Financing Arrangements
7. Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy
8. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
9. Northwest Biotherapeutics Addresses Recent Market Activity
10. Cell Therapeutics, Inc. (CTI) to Present at Life Science Innovation Northwest
11. Registration Open for WBBAs Life Science Innovation Northwest 2011 Event Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- DeepResearchReports.com adds "2014 Market Research Report on ... Report on Global Ammonium Acetate Industry" reports to ... http://photos.prnewswire.com/prnh/20140902/141873 2014 Market Research ... professional and in-depth research report on ... The report introduces Sodium Bicarbonate basic information, definition, ...
(Date:9/2/2014)... The Little Company of Mary Hospital in Evergreen ... square-foot West Pavilion patient tower, which included the selection ... for the nurse’s lounge near the maternity ward. ... Hospital’s $180 million, four-year Campus Transformation project is ... the West Pavilion tower to the North Pavilion, as ...
(Date:9/2/2014)... and BELLINGHAM, Washington, USA (PRWEB) September 02, 2014 ... International Year of Light and Light-based Technologies (IYL 2015) ... top awards from SPIE, the international society for ... Awards were presented to Levinson and Dudley along with ... Medal of the Society won by James Harrington, during ...
(Date:9/2/2014)... HILL and NEW PROVIDENCE, N.J. ... America, Inc. is a corporate sponsor for MassBio,s ... its sister organization, the MassBioEd Foundation. The event will ... Golf Club in Plymouth, Massachusetts . ... biotechnology education in Massachusetts through ...
Breaking Biology Technology:Sodium Bicarbonate Market & Ammonium Acetate Industry: China & Global Analysis 2Sodium Bicarbonate Market & Ammonium Acetate Industry: China & Global Analysis 3Sodium Bicarbonate Market & Ammonium Acetate Industry: China & Global Analysis 4Sodium Bicarbonate Market & Ammonium Acetate Industry: China & Global Analysis 5Tufftec® Lockers from Scranton Products Selected by Little Company of Mary Hospital Near Chicago to Create an Uplifting Environment 2Tufftec® Lockers from Scranton Products Selected by Little Company of Mary Hospital Near Chicago to Create an Uplifting Environment 3Levinson, Dudley Win SPIE Directors’ and President’s Awards 2Levinson, Dudley Win SPIE Directors’ and President’s Awards 3Levinson, Dudley Win SPIE Directors’ and President’s Awards 4Linde helps fund STEM education in Massachusetts 2Linde helps fund STEM education in Massachusetts 3
... Vista Partners announced,today that it has updated ... ABMC ) and maintains its twelve month target ... Vista Partners stated, "Sales,internationally continue to increase and ... exposure in numerous testing centers, continue,to increase as ...
... Enrich Current Coverage With Regional Perspective, PHILADELPHIA ... leading provider of information solutions to the worldwide,research ... social,science journals have been added to Web of ... target a regional rather than,international audience by approaching ...
... March 31, 2008 Human,Pheromone Sciences, Inc. (OTC Bulletin ... the three months and the year ended,December 31, 2007. ... was $389,000, representing a 6% decrease from revenues of ... income of $38,000 ($.01 per,share) as compared with a ...
Cached Biology Technology:Vista Partners Updates Coverage; Maintains $3.20 Target Price 2Thomson Scientific Begins Expansion of Web of Science 2Human Pheromone Sciences Announces Quarterly and Full Year Results 2Human Pheromone Sciences Announces Quarterly and Full Year Results 3Human Pheromone Sciences Announces Quarterly and Full Year Results 4
(Date:9/2/2014)... a U.S. suburb , Observations and mapping by ... hours and days after the August 24 earthquake in ... caused so much damage in the region, according to ... the American Geophysical Union. , From ... to Direct Our Curiosity , Selecting where the ...
(Date:9/2/2014)... 3, The Field Museum will present the prestigious Parker/Gentry ... his commitment to biodiversity conservation awareness. The Parker/Gentry Award ... outstanding individual, team or organization whose efforts have had ... heritage and whose actions can serve as a model ... Mongabay.com, an environmental science and conservation news website that ...
(Date:9/2/2014)... Tithonian Konservat-Lagersttte of lithographic limestone is well known ... fossils from that area (for example, Archaeopteryx). Now, ... insects in the French equivalent of these outcrops ... the oldest known water treader. , Despite the ... fewer fossils have been obtained from the Late ...
Breaking Biology News(10 mins):This week From AGU: California earthquake, future Mars rovers, models underestimate ozone 2Exceptionally well preserved insect fossils from the Rhône Valley 2
... the first study evaluating the use of human urine mixed ... found that the combination can be substituted for costly synthetic ... risk of disease for consumers. The study appears in the ... Chemistry , a bi-weekly publication. In the study, ...
... the energy consumption of cells have a different structure and ... people, according to a new study from the Swedish medical ... researchers believe that these ,epigenetic mutations, might have a key ... Type II diabetes is characterised by a lower sensitivity ...
... This release is available in German . ... know-how in micro- and nanotechnologies for users from science ... KIT is starting operation: Ten leading institutions from research ... a total of 36 high-tech installations along with the ...
Cached Biology News:Scientific pathways into the nanoworld 2Scientific pathways into the nanoworld 3
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
One-step, colorimetric, linear detection range 0.7 mg/dL to 300 mg/dL. Procedure: 10 min....
XBP1 Antibody...
... Designed to histochemically ... in distinct pH in ... sections. The specific marker ... senescent cells (not found ...
Biology Products: